Thierry Piéton compensation by year
Medtronic Summary Compensation Table · all 2 fiscal years held| Component | FY2025 | FY2026 |
|---|---|---|
| Salary | $138,517 | $849,648 |
| Bonus | $0 | $2,000,000 |
| Stock awards | $4,190,625 | $3,170,470 |
| Option awards | $600,056 | $1,200,139 |
| Non-equity incentive | $141,975 | $963,050 |
| Pension and deferred compensation | $0 | $0 |
| All other | $141,274 | $404,079 |
| Total | $5,212,448 | $8,587,387 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Medtronic plc DEF 14A filed August 17, 2026, accession 0001613103-26-000010, and prior-year filings. Open the filing on EDGAR.
Equity holdings
unvested awards at FY2026 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 22,251 | $1,853,953 | — |
| RSU | 18,383 | $1,531,672 | — |
| RSU | 11,029 | $918,936 | — |
| RSU | 8,901 | $741,631 | — |
| RSU | 4,412 | $367,608 | — |
| Option | 61,338 | — | $91.97 |
| Option | 22,181 | — | $94.30 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Medtronic plc's FY2026 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments Medtronic discloses, by trigger · FY2026| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Involuntary termination without cause | $3,570,000 | $1,531,597 | $20,000 | $5,121,597 |
| Change in control and involuntary termination | $6,402,200 | $5,413,594 | $548,459 | $12,364,253 |
Per the Potential Payments Upon Termination or Change in Control table in Medtronic plc's FY2026 proxy. Estimates as the company printed them; a dash means it printed no figure.
Medtronic’s named executive officers, FY2026
as the company reported each| Named executive officer | Role | FY2026 total |
|---|---|---|
| Geoffrey Martha | Chairman and Chief Executive Officer | $22,940,252 |
| Thierry Piéton · this page | Executive Vice President and Chief Financial Officer | $8,587,387 |
| Brett Wall | Former Executive Vice President and President, Neuroscience Portfolio | $6,921,425 |
| Michael Marinaro | Executive Vice President and President, Medical Surgical Portfolio and Americas | $6,832,836 |
| Michelle Quinn | Executive Vice President, General Counsel and Secretary | $6,719,170 |
The full Medtronic compensation record
free company briefThis page is one person within Medtronic's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Medtronic's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Medtronic's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat